{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:37:22Z","timestamp":1793756242477,"version":"4.6.1"},"reference-count":68,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Gastric cancer is among the leading causes of cancer-related deaths worldwide. Modern treatment approaches include nanoparticles (NPs) designed to target cancer cells, which release a therapeutic cargo facilitating the inhibition of their expansion, thereby improving anti-tumor therapies. The success of NPs, created to deliver anticancer agents and biologically active compounds, may depend on selecting the way to target cancer cells. This study focused on examining the effects of NPs made of polylactic acid (PLA) with histamine (His) end groups and loaded with 5-fluorouracil (5-FU), a known anticancer drug (PLA-His-5-FU), on human gastric cancer AGS cells in vitro. The incubation of AGS cells with PLA-His-FU NPs resulted in diminished mitochondrial membrane potential and the induction of cell apoptosis, along with cell cycle arrest and the reduction of cell proliferation. Furthermore, the NPs tested provoked the secretion of pro-inflammatory cytokines tumor necrosis factor alpha (TNF-\u03b1) and interleukin (IL)-1\u03b2 by AGS cells and induced the activation of the nuclear factor kappa B (NF-\u03baB) signaling pathway in THP-1 blue monocytes, which indicates the ability to promote the development of a milieu for the infiltration and activation of immunocompetent cells. NPs did not increase intracellular adhesion molecule (ICAM-1) deposition on AGS cells, thus potentially preventing the distribution of cancer cells. In conclusion, PLA-His-5-FU NPs show promising anticancer activity for gastric cancer AGS cells in vitro, better than PLA-OH-5-FU, and can be used in further in vivo studies to confirm this activity.<\/jats:p>","DOI":"10.3390\/molecules31142520","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:54:13Z","timestamp":1784534053000},"page":"2520","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanistic Insights into the Action of Histamine-Functionalized PLA Nanoparticles Loaded with 5-Fluorouracil Against Gastric Cancer Cells In Vitro"],"prefix":"10.3390","volume":"31","author":[{"given":"Patrycja","family":"Jaroniek","sequence":"first","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12\/16, 90-237 Lodz, Poland"},{"name":"Bio-Med-Chem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, University of Lodz, Matejki 21\/23, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Brzezi\u0144ski","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"\u015awiniarska","sequence":"additional","affiliation":[{"name":"Bio-Med-Chem Doctoral School of the University of Lodz and Lodz Institutes of the Polish Academy of Sciences, University of Lodz, Matejki 21\/23, 90-237 Lodz, Poland"},{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Chmiela","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12\/16, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5231-5341","authenticated-orcid":false,"given":"Weronika","family":"Gonciarz","sequence":"additional","affiliation":[{"name":"Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12\/16, 90-237 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mamun, T.I., Younus, S., and Rahman, M.H. (2024). Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: An updated review. Cancer Treat. Res. Commun., 41.","DOI":"10.1016\/j.ctarc.2024.100845"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canlet.2013.08.016","article-title":"Helicobacter pylori-induced gastric inflammation and gastric cancer","volume":"345","author":"Wang","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_4","first-page":"667","article-title":"Global, regional, and national burden of early-onset gastric cancer","volume":"21","author":"Tan","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v23.i9.1521","article-title":"Host pathogen interactions in Helicobacter pylori related gastric cancer","volume":"23","author":"Chmiela","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guan, W.L., He, Y., and Xu, R.H. (2023). Gastric cancer treatment: Recent progress and future perspectives. J. Hematol. Oncol., 16.","DOI":"10.1186\/s13045-023-01451-3"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Samasca, G., Burz, C., Pintea, I., Muntean, A., Deleanu, D., Lupan, I., and Bintintan, V. (2024). A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update. Pharmaceuticals, 17.","DOI":"10.3390\/ph17091121"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Patra, J.K., Das, G., Fraceto, L.F., Campos, E.V.R., Rodriguez-Torres, M.D.P., Acosta-Torres, L.S., Diaz-Torres, L.A., Grillo, R., Swamy, M.K., and Sharma, S. (2018). Nano based drug delivery systems: Recent developments and prospects. J. Nanobiotechnol., 16.","DOI":"10.1186\/s12951-018-0392-8"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Adepu, S., and Ramakrishna, S. (2021). Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 26.","DOI":"10.3390\/molecules26195905"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Brzezinski, M., Gonciarz, W., Kost, B., and Chmiela, M. (2023). Can histamine cause an enhancement of the cellular uptake and cytotoxicity of doxorubicin-loaded polylactide nanoparticles?. Eur. J. Pharm. Sci., 185.","DOI":"10.1016\/j.ejps.2023.106438"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Valencia-Lazcano, A.A., Hassan, D., Pourmadadi, M., Shamsabadipour, A., Behzadmehr, R., Rahdar, A., Medina, D.I., and D\u00edez-Pascual, A.M. (2023). 5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy. Eur. J. Med. Chem., 246.","DOI":"10.1016\/j.ejmech.2022.114995"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ugorji, O.L., Umeh, O.N.C., Agubata, C.O., Adah, D., Obitte, N.C., and Chukwu, A. (2022). The effect of noisome preparation methods in encapsulating 5-fluorouracil and real time cell assay against HCT-116 colon cancer cell line. Heliyon, 8.","DOI":"10.2139\/ssrn.4187496"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Cadinoiu, A.N., Rata, D.M., Atanase, L.I., Mihai, C.T., Bacaita, S.E., and Popa, M. (2021). Formulations Based on Drug Loaded Aptamer-Conjugated Liposomes as a Viable Strategy for the Topical Treatment of Basal Cell Carcinoma-In Vitro Tests. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060866"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Khodarahmi, M., Abbasi, H., Kouchak, M., Mahdavinia, M., Handali, S., and Rahbar, N. (2022). Nanoencapsulation of aptamer-functionalized 5-Fluorouracil liposomes using alginate\/chitosan complex as a novel targeting strategy for colon-specific drug delivery. J. Drug Deliv. Sci. Technol., 71.","DOI":"10.1016\/j.jddst.2022.103299"},{"key":"ref_16","first-page":"1","article-title":"Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer","volume":"23","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Karami, M.H., and Abdouss, M. (2024). Cutting-edge tumor nanotherapy: Advancements in 5-fluorouracil Drug-loaded chitosan nanoparticles. Inorg. Chem. Commun., 164.","DOI":"10.1016\/j.inoche.2024.112430"},{"key":"ref_18","first-page":"1685","article-title":"Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy","volume":"6","author":"Nair","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopha.2018.05.124","article-title":"Polymeric nano-encapsulation of 5-fluorouracil enhances anticancer activity and ameliorates side effects in solid Ehrlich carcinoma-bearing mice","volume":"105","author":"Haggag","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2016.11.012","article-title":"Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumor activity of 5-fluorouracil","volume":"516","author":"Arias","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.2147\/DDDT.S140797","article-title":"Irinotecan and 5-fluorouracil co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy","volume":"11","author":"Gao","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wu, P., Zhou, Q., Zhu, H., Zhuang, Y., and Bao, J. (2020). Enhanced antitumor efficacy in colon cancer using EGF-functionalized PLGA nanoparticles loaded with 5-fluorouracil and perfluorocarbon. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-06803-7"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1476-5381.2009.00288.x","article-title":"Chemical vectors for gene delivery: A current review on polymers, peptides and lipids containing histidine or imidazole residues","volume":"157","author":"Midoux","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Johnson, R.P., John, J.V., and Kim, I. (2014). Poly(L-histidine)-containing polymer bioconjugate hybrid materials for pH-responsive delivery. Appl. Polym. Sci., 131.","DOI":"10.1002\/app.40796"},{"key":"ref_25","first-page":"5577","article-title":"The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles","volume":"7","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cpr.12192","article-title":"Independent effect of polymeric nanoparticle zeta potential\/surface charge on cellular interaction and cytotoxicity","volume":"48","author":"Shao","year":"2015","journal-title":"Cell Prolif."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Arai, H., and Nakajima, T.E. (2020). Recent Developments of Systemic Chemotherapy for Gastric Cancer. Cancers, 12.","DOI":"10.3390\/cancers12051100"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: A comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gao, L., Fansu, M., Yang, Z., Lafuente-Merchan, M., Merino Fernandez, L., Cao, Y., Kusamori, L., Nishikawa, M., Itakura, S., and Chen, J. (2024). Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives. Biomed. Pharmacother., 179.","DOI":"10.1016\/j.biopha.2024.117327"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/iub.2215","article-title":"Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons","volume":"72","author":"Majidinia","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1080\/10717544.2022.2079771","article-title":"Recent advances in anti-multidrug resistance for nano-drug delivery system","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.12998\/wjcc.v10.i16.5146","article-title":"Nanotechnology in diagnosis and therapy of gastrointestinal cancer","volume":"10","author":"Liang","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_33","first-page":"226","article-title":"Polymeric Nanoparticles in Cancer Chemotherapy: A Narrative Review","volume":"51","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): Nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ezike, T.C., Okpala, U.S., Onoja, U.L., Nwike, C.P., Ezeako, E.C., Okpara, O.J., Okoroafor, C.C., Eze, S.C., Kalu, O.L., and Odoh, E.C. (2023). Advances in drug delivery systems, challenges and future directions. Heliyon, 9.","DOI":"10.1016\/j.heliyon.2023.e17488"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1039\/D2TB00469K","article-title":"Progress in the drug encapsulation of poly(lactic-co-glycolic acid) and folate-decorated poly(ethylene glycol)-poly(lactic-co-glycolic acid) conjugates for selective cancer treatment","volume":"10","author":"Dodda","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jan, N., Madni, A., Khan, S., Shah, H., Akram, F., Khan, A., Ertas, D., Bostanudin, M.F., Contag, C.H., and Ashammakhi, N. (2023). Biomimetic cell membrane-coated poly(lactic-co-glycolic acid) nanoparticles for biomedical applications. Bioeng. Transl. Med., 8.","DOI":"10.1002\/btm2.10441"},{"key":"ref_38","first-page":"487","article-title":"Nano drug delivery and targeting for the treatment of gastric cancer: A review","volume":"10","author":"Jawahar","year":"2018","journal-title":"J. Pharm. Sci. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Subhan, M.A., Yalamarty, S.S.K., Filipczak, N., Parveen, F., and Torchilin, V.P. (2021). Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment. J. Pers. Med., 11.","DOI":"10.3390\/jpm11060571"},{"key":"ref_40","first-page":"328","article-title":"A Review on Targeted Drug Delivery: Its Entire Focus on Advanced Therapeutics and Diagnostics","volume":"2","author":"Rani","year":"2014","journal-title":"Sch. J. Appl. Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Pan, Y., Xue, X., and Liang, X.J. (2024). Nanotechnology-Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives. Adv. NanoBiomed Res., 4.","DOI":"10.1002\/anbr.202300129"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Longobardi, G., Moore, T.L., Cinte, C., Ungaro, F., Satchi-Fainaro, R., and Quaglia, F. (2024). Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 16.","DOI":"10.1002\/wnan.1990"},{"key":"ref_43","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2016.01.012","article-title":"Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics study","volume":"84","author":"Altmeyer","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.biomaterials.2013.12.045","article-title":"SM5-1-Conjugated PLA nanoparticles loaded with 5-fluorouracil for targeted hepatocellular carcinoma imaging and therapy","volume":"35","author":"Ma","year":"2014","journal-title":"Biomaterials"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-8-103","article-title":"Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles","volume":"8","author":"Li","year":"2008","journal-title":"BMC Cancer"},{"key":"ref_47","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems\u2014A review","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Dharmayanti, C., Gillam, T.A., Haggett, K.D., Simpson, J.D., Greish, K., and Thurecht, K.J. (2021). Strategies for the development of pH-responsive synthetic polypeptide-based nanoparticles for cancer therapy. Polymers, 13.","DOI":"10.3390\/polym13040624"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gutjahr, A., Phelip, C., Coolen, A.L., Monge, C., Boisgard, A.S., Paul, S., and Verrier, B. (2016). Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting. Vaccines, 4.","DOI":"10.3390\/vaccines4040034"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2014.06.024","article-title":"Surface modified PLGA nanoparticles for brain targeting of Bacoside-A","volume":"63","author":"Jose","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Turanl\u0131., Y., and Acart\u00fcrk, F. (2022). Preparation and characterization of colon-targeted pH\/Time-dependent nanoparticles using anionic and cationic polymethacrylate polymers. Eur. J. Pharm. Sci., 171.","DOI":"10.1016\/j.ejps.2022.106122"},{"key":"ref_52","unstructured":"(2009). Biological Evaluation of Medical Devices\u2014Part 5: Tests for In Vitro Cytotoxicity (Standard No. ISO 10993-5)."},{"key":"ref_53","first-page":"215","article-title":"Histamine and histamine receptor regulation of gastrointestinal cancers","volume":"1","author":"Kennedy","year":"2012","journal-title":"Transl. Gastrointest. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/bph.14535","article-title":"Histamine receptors and cancer pharmacology: An update","volume":"177","author":"Massari","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_55","first-page":"361","article-title":"Chitosan nanoparticles for combined drug delivery and magnetic hyperthermia: From preparation to in vitro studies","volume":"10","author":"Sanz","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical Pharmacology of 5-Fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Begum, H.M., and Shen, K. (2023). Intracellular and microenvironmental regulation of mitochondrial membrane potential in cancer cells. WIREs Mech. Dis., 15.","DOI":"10.1002\/wsbm.1595"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Rosania, R., Varbanova, M., Wex, T., Langner, C., Bornschein, J., Giorgio, F., Ierardi, E., and Malfertheiner, P. (2017). Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0640-7"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Li, X., Yin, X., Mi, L., Li, N., Li, S., and Yin, F. (2024). Identification of a novel apoptosis-related genes signature to improve gastric cancer prognosis prediction. Heliyon, 10.","DOI":"10.1016\/j.heliyon.2024.e33795"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.redox.2014.12.011","article-title":"Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria","volume":"4","author":"Zhong","year":"2015","journal-title":"Redox Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7150\/ijbs.10248","article-title":"5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells","volume":"11","author":"Xu","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/bjc.2014.70","article-title":"Leptin-mediated regulation of ICAM-1 is Rho\/ROCK dependent and enhances gastric cancer cell migration","volume":"110","author":"Dong","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.omto.2020.08.009","article-title":"Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer","volume":"18","author":"Jung","year":"2020","journal-title":"Mol. Ther.-Oncolytics"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Brzezinski, M., Kost, B., Gonciarz, W., Krupa, A., Socka, M., and Rogala, M. (2021). Nanocarriers based on block copolymers of l-proline and lactide: The effect of core crosslinking versus its pH-sensitivity on their cellular uptake. Eur. Polym. J., 156.","DOI":"10.1016\/j.eurpolymj.2021.110572"},{"key":"ref_65","first-page":"215","article-title":"5-Fluorouracil as a photosensitiser","volume":"19","author":"Pascu","year":"2005","journal-title":"In Vivo"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1006\/bbrc.1995.2693","article-title":"HPLC analysis of 5-FU and FdUMP in tissue and serum","volume":"216","author":"Wrightson","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gonciarz, W., Krupa, A., Hinc, K., Obuchowski, M., Moran, A.P., Gajewski, A., and Chmiela, M. (2019). The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220636"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Gonciarz, W., Chmiela, M., Kost, B., Pi\u0105tczak, E., and Brzezinski, M. (2021). Stereocomplexed microparticles loaded with Salvia cadmica Boiss. extracts for enhancement of immune response towards Helicobacter pylori. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-34321-6"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/14\/2520\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:54:26Z","timestamp":1784534066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/14\/2520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":68,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["molecules31142520"],"URL":"https:\/\/doi.org\/10.3390\/molecules31142520","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}